Immunome, Inc. (IMNM)
18.15
-0.55
(-2.94%)
USD |
NASDAQ |
Nov 13, 10:06
Immunome Free Cash Flow (Quarterly) : -61.24M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -61.24M |
| June 30, 2026 | -63.87M |
| March 31, 2026 | -61.64M |
| December 31, 2025 | -51.95M |
| September 30, 2025 | -41.63M |
| June 30, 2025 | -50.31M |
| March 31, 2025 | -56.72M |
| December 31, 2024 | -43.19M |
| September 30, 2024 | -35.71M |
| June 30, 2024 | -25.74M |
| March 31, 2024 | -13.33M |
| December 31, 2023 | -17.81M |
| September 30, 2023 | -8.65M |
| June 30, 2023 | -6.008M |
| Date | Value |
|---|---|
| March 31, 2023 | 24.07M |
| December 31, 2022 | -6.755M |
| September 30, 2022 | -7.571M |
| June 30, 2022 | -8.23M |
| March 31, 2022 | -6.382M |
| December 31, 2021 | -6.819M |
| September 30, 2021 | -4.171M |
| June 30, 2021 | -3.749M |
| March 31, 2021 | -3.566M |
| December 31, 2020 | -6.108M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -2.119M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Revolution Medicines, Inc. | -419.35M |
| Erasca, Inc. | -27.28M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |